NeuroOne Medical Technologies (NASDAQ:NMTC) Trading 2.3% Higher

NeuroOne Medical Technologies Co. (NASDAQ:NMTCGet Free Report) traded up 2.3% on Monday . The stock traded as high as $0.96 and last traded at $0.95. 50,256 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 173,482 shares. The stock had previously closed at $0.93.

NeuroOne Medical Technologies Trading Up 2.3 %

The firm has a 50 day moving average of $1.13 and a two-hundred day moving average of $1.27. The stock has a market capitalization of $26.19 million, a PE ratio of -1.64 and a beta of 0.73.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NeuroOne Medical Technologies stock. Wealth Alliance Advisory Group LLC bought a new position in NeuroOne Medical Technologies Co. (NASDAQ:NMTCFree Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 19,500 shares of the company’s stock, valued at approximately $31,000. Wealth Alliance Advisory Group LLC owned 0.08% of NeuroOne Medical Technologies at the end of the most recent reporting period. Institutional investors own 16.07% of the company’s stock.

About NeuroOne Medical Technologies

(Get Free Report)

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders.

Featured Articles

Receive News & Ratings for NeuroOne Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroOne Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.